Business Segments · Total Assets

Diagnostic Products — Total Assets

Abbott Diagnostic Products — Total Assets increased by 16.4% to $9.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.8%, from $7.84B to $9.63B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ1 2026
Rolls up toTotal Assets

How to read this metric

Growth in assets relative to sales may indicate capital expansion, while a decline could suggest asset divestiture or improved asset turnover.

Detailed definition

The sum of all assets, including inventory, property, plant, equipment, and intangible assets, specifically attributed t...

Peer comparison

Standard balance sheet metric for segment reporting.

Metric ID: abt_segment_diagnostic_products_total_assets

Historical Data

9 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value7.7B8B7.8B7.7B7.8B8.2B8.2B8.3B9.6B
QoQ Change+3.7%-2.7%-1.1%+2.1%+4.3%+0.3%+0.9%+16.4%
YoY Change+3.7%-2.7%-1.1%+7.7%+22.8%
Range7.7B9.6B
CAGR+11.8%
Avg YoY Growth+6.1%
Median YoY Growth+3.7%
Current Streak5 quarters growth

Frequently Asked Questions

What is Abbott's diagnostic products — total assets?
Abbott (ABT) reported diagnostic products — total assets of $9.63B in Q1 2026.
How has Abbott's diagnostic products — total assets changed year-over-year?
Abbott's diagnostic products — total assets increased by 22.8% year-over-year, from $7.84B to $9.63B.
What does diagnostic products — total assets mean?
The total value of resources and assets held by the diagnostics segment.